REFERENCES
- Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JN, Vatopoulos AC. On the incidence of antibiotic resistance among Gram-negative rods isolated in Greek hospitals. J Hosp Infect 1993; 24: 233–237.
- Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635–648.
- Legakis NJ, Tzouvelekis LS, Hatzoudis G, et al. Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lacta-mase. J Hosp Infect 1995; 31: 177–187.
- Prinarakis EE, Tzelepi E, Gazouli M, Mentis AF, Tzouvelekis LS. Characterization of a novel SHV beta-lacta-mase variant that resembles the SHV-5 enzyme. FEMS Microbiol Lett 1996; 139: 229–234.
- Hu1ton CS, Higgins CF, Sharp PM. ERIC sequences: a novel family of repetitive elements in the genomes of Escherichia coli, Salmonella typhimurium and other enter-°bacteria. Mol Microbiol 1991; 5: 825-834.
- Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–584.
- Gazouli M, Kaufmann ME, Tzelepi E, Dimopoulou H, Paniara 0, Tzouvelekis LS. Study of an outbreak of cefoxitin-resistant Klebsiella pneumoniae in a general hospital. J Clin Microbiol 1997; 35: 508–510.
- Medeiros AA. Evolution and dissemination of beta-lacta-mases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 1997; 24(Suppl 1): 19–45.
- French GL, Shannon KP, Simmons N. Hospital out-break of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor com-binations by hyperproduction of SHV-5. J Clin Microbiol 1996; 34: 358–363.
- Tzouvelekis LS, Tzelepi E, Prinarakis E, et al. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals. J Clin Microbiol 1998; 36: 266–268.
- Martinez-Martinez L, Hernadez-Ales S, Alberti S, Tomas JM, Benedi VJ, Jacoby GA. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 342–348.